Table 1.
Correlations between membraneous E-CAD expression at advanced stages (III, IV) and OC clinical pathological features using the cut-off point (no expression (0) vs (positive expression (1+,2+,3+))
| Clinico-pathological Features | Number Of samples | Significance |
|---|---|---|
| Age | Number (%) | p-value |
| ‹ 50 | 64 (56%) | 0.518 |
| › 50 | 51 (44%) | |
| Lymph Node status | ||
| Positive | 19 (32%) | 0.844 |
| Negative | 41 (68%) | |
| Histological subtypes | ||
| Serous | 52 (47%) | 0.0001 |
| Mucinous | 23 (21%) | |
| Other types | 36 (32%) | |
| Tumor Size | ||
| 1–5 cm | 21 (19%) | 0.441 |
| 6–10 cm | 33 (29%) | |
| >10 cm | 59 (52%) | |
| Tumor Grade | ||
| Grade 1 | 14 (14%) | 0.060 |
| Grade 2 | 16 (17%) | |
| Grade 3 | 67 (69%) | |
| Parity | ||
| Parous | 51 (60%) | 0.077 |
| Nulliparous | 34 (40%) | |
| Body mass index (BMI) | ||
| < 23 | 7 (8%) | 0.623 |
| 23–26 | 23 (27%) | |
| >26 | 55 (65%) | |
| Recurrence | ||
| Negative | 46 (53%) | 0.665 |
| positive | 40 (47%) | |
| Tumor Stage | ||
| Low Stage | 37 (36%) | 0.069 |
| High Stage | 66 (64%) | |
| Endpoint Status | ||
| Deceased | 34 (35%) | 0.394 |
| Living | 63 (65%) |